Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Artelo Biosciences, Inc.
Market Cap
$1.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.48M
Operating Margin
-78.72%
TTM Avg
-104.88%
3Y Avg
-431.56%
5Y Avg
-397.22%
Market Cap
$1.49M
Operating Margin
-1250.11%
TTM Avg
-662.88%
3Y Avg
-389.78%
5Y Avg
-16081.34%
Market Cap
$1.50M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.54M
Operating Margin
-348.43%
TTM Avg
-378.38%
3Y Avg
-440.18%
5Y Avg
-397.59%
Market Cap
$1.17M
Operating Margin
-40873.19%
TTM Avg
-20436.60%
3Y Avg
-10586.14%
5Y Avg
-7186.89%
Market Cap
$1.17M
Operating Margin
-25.95%
TTM Avg
-20.05%
3Y Avg
-30.75%
5Y Avg
-40.42%
Market Cap
$1.14M
Operating Margin
-7.41%
TTM Avg
-3.38%
3Y Avg
2.80%
5Y Avg
2.80%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| INVO Fertility, Inc. (IVF)vs › | $1.48M | -78.72% | -104.88% | -431.56% | -397.22% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -1250.11% | -662.88% | -389.78% | -16081.34% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Curis, Inc. (CRIS)vs › | $1.54M | -348.43% | -378.38% | -440.18% | -397.59% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.17M | -40873.19% | -20436.60% | -10586.14% | -7186.89% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -25.95% | -20.05% | -30.75% | -40.42% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -7.41% | -3.38% | 2.80% | 2.80% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-11-30 | 0.00% |
| 2021-08-31 | 0.00% |
| 2021-05-31 | 0.00% |
| 2021-02-28 | 0.00% |
| 2020-11-30 | 0.00% |
| 2020-08-31 | 0.00% |
| 2020-05-31 | 0.00% |
| 2020-02-29 | 0.00% |
| 2019-11-30 | 0.00% |
| 2019-08-31 | 0.00% |
| 2019-05-31 | 0.00% |
| 2019-02-28 | 0.00% |
| 2018-11-30 | 0.00% |
| 2018-08-31 | 0.00% |
| 2018-05-31 | 0.00% |
| 2018-02-28 | 0.00% |
| 2017-11-30 | 0.00% |
| 2017-08-31 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
